GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Invacare Corp (OTCPK:IVCRQ) » Definitions » ROE %

Invacare (Invacare) ROE % : -259.32% (As of Mar. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Invacare ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Invacare's annualized net income for the quarter that ended in Mar. 2023 was $-164.7 Mil. Invacare's average Total Stockholders Equity over the quarter that ended in Mar. 2023 was $63.5 Mil. Therefore, Invacare's annualized ROE % for the quarter that ended in Mar. 2023 was -259.32%.

The historical rank and industry rank for Invacare's ROE % or its related term are showing as below:

IVCRQ' s ROE % Range Over the Past 10 Years
Min: -108.31   Med: -10.46   Max: 5.12
Current: -108.31

During the past 13 years, Invacare's highest ROE % was 5.12%. The lowest was -108.31%. And the median was -10.46%.

IVCRQ's ROE % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.125 vs IVCRQ: -108.31

Invacare ROE % Historical Data

The historical data trend for Invacare's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invacare ROE % Chart

Invacare Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.23 -15.97 -8.81 -16.50 -67.47

Invacare Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -47.47 -52.10 -120.20 -101.53 -259.32

Competitive Comparison of Invacare's ROE %

For the Medical Instruments & Supplies subindustry, Invacare's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invacare's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Invacare's ROE % distribution charts can be found below:

* The bar in red indicates where Invacare's ROE % falls into.



Invacare ROE % Calculation

Invacare's annualized ROE % for the fiscal year that ended in Dec. 2022 is calculated as

ROE %=Net Income (A: Dec. 2022 )/( (Total Stockholders Equity (A: Dec. 2021 )+Total Stockholders Equity (A: Dec. 2022 ))/ count )
=-101.071/( (218.489+81.092)/ 2 )
=-101.071/149.7905
=-67.47 %

Invacare's annualized ROE % for the quarter that ended in Mar. 2023 is calculated as

ROE %=Net Income (Q: Mar. 2023 )/( (Total Stockholders Equity (Q: Dec. 2022 )+Total Stockholders Equity (Q: Mar. 2023 ))/ count )
=-164.708/( (81.092+45.939)/ 2 )
=-164.708/63.5155
=-259.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2023) net income data. ROE % is displayed in the 30-year financial page.


Invacare  (OTCPK:IVCRQ) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2023 )
=Net Income/Total Stockholders Equity
=-164.708/63.5155
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-164.708 / 661.924)*(661.924 / 766.5425)*(766.5425 / 63.5155)
=Net Margin %*Asset Turnover*Equity Multiplier
=-24.88 %*0.8635*12.0686
=ROA %*Equity Multiplier
=-21.48 %*12.0686
=-259.32 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2023 )
=Net Income/Total Stockholders Equity
=-164.708/63.5155
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-164.708 / -160.948) * (-160.948 / -39.86) * (-39.86 / 661.924) * (661.924 / 766.5425) * (766.5425 / 63.5155)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0234 * 4.0378 * -6.02 % * 0.8635 * 12.0686
=-259.32 %

Note: The net income data used here is four times the quarterly (Mar. 2023) net income data. The Revenue data used here is four times the quarterly (Mar. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Invacare ROE % Related Terms

Thank you for viewing the detailed overview of Invacare's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Invacare (Invacare) Business Description

Traded in Other Exchanges
N/A
Address
One Invacare Way, Elyria, OH, USA, 44035-4190
Invacare Corp makes and distributes medical equipment used in non-acute care settings. Its products are primarily sold to home medical equipment providers, residential living operators, distributors, and government health services. The firm sells products in three categories: mobility and seating, lifestyle, and respiratory therapy. Its mobility and seating products include power wheelchairs, custom manual wheelchairs, and positioning cushions. Its lifestyle products include manual wheelchairs, crutches, walkers, and homecare beds. Its respiratory products include stationary and portable oxygen concentrators and non-delivery oxygen technology. Invacare receives the largest proportion of revenue from sales in Europe.
Executives
Tenor Opportunity Master Fund, Ltd. 10 percent owner 810 SEVENTH AVENUE, SUITE 1905, NEW YORK NY 10019
Randel G Owen director C/O EMERGENCY MEDICAL SERVICES CORP, 6200 SOUTH SYRACUSE WAY, GREENWOOD VILLAGE CO 80111
Kimberly Herman director 3 HUNTINGTON QUADRANGLE, STE 25, MELVILLE NY 11747
Marec Elden Edgar director 1420 KENSINGTON ROAD, SUITE 220, OAK BROOK IL 60523
Elliot Bossen 10 percent owner 3100 TOWER BLVD, UNIVERSITY TOWER STE 1104, DURHAM NC 27707
Silverback Asset Management Llc 10 percent owner 1414 RALEIGH ROAD, SUITE 250, CHAPEL HILL NC 27517
Peter J. Kuipers director 590 E. MIDDLEFEILD ROAD, MOUNTAIN VIEW CA 94043
Tenor Capital Management Co., L.p. 10 percent owner 810 SEVENTH AVENUE, SUITE 1905, NEW YORK NY 10019
Pm Manager Fund, Spc-segregated Portfolio 33 10 percent owner 190 ELGIN AVE, GEORGE TOWN, GRAND CAYMAN E9 KYI-9005
Dov Gertzulin 10 percent owner C/O DG CAPITAL MANAGEMENT, LLC, 460 PARK AVENUE, 22ND FLOOR, NEW YORK NY 10022
Dg Capital Management, Llc 10 percent owner 460 PARK AVENUE, 22ND FLOOR, NEW YORK NY 10022
Endurant Capital Management Lp 10 percent owner 66 BOVET ROAD, SUITE 353, SAN MATEO CA 94402
Abraham T Han director 51 MIDLAND AVENUE, WYCKOFF NJ 07481
Dg Value Partners Ii Master Fund, Lp 10 percent owner 460 PARK AVENUE, 22ND FLOOR, NEW YORK NY 10022
Quang Minh Pham 10 percent owner 66 BOVET ROAD, SUITE 353, SAN MATEO CA 94402